Top compounds associated with response to TMEM33


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.05
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.071 0.05
mRNA TGX221 CTRPv2 pan-cancer AAC -0.072 0.05
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC 0.072 0.05
mRNA RG-108 CTRPv2 pan-cancer AAC -0.069 0.06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.06
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.064 0.06
mRNA Curcumin CTRPv2 pan-cancer AAC -0.066 0.06
mRNA DBeQ CTRPv2 pan-cancer AAC -0.07 0.06
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.073 0.06
Download CSV